Dublin - Research and Markets (http://www.researchandmarkets.com/research/dc444e6b/fracture_pipelin) has announced the addition of Global Markets Direct's new report "Fracture - Pipeline Review, H1 2012" to their offering.
Global Markets Direct's, 'Fracture - Pipeline Review, H1 2012', provides an overview of the Fracture therapeutic pipeline. This report provides information on the therapeutic development for Fracture, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Fracture. 'Fracture - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Scope
- A snapshot of the global therapeutic scenario for Fracture.
- A review of the Fracture products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Fracture pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Key Topics Covered:
- List of Tables
- List of Figures
- Introduction
- Global Markets Direct Report Coverage
- Fracture Overview
- Therapeutics Development
- An Overview of Pipeline Products for Fracture
- Fracture Therapeutics under Development by Companies
- Fracture Therapeutics under Investigation by Universities/Institutes
- Late Stage Products
- Comparative Analysis
- Mid Clinical Stage Products
- Comparative Analysis
- Early Clinical Stage Products
- Comparative Analysis
- Fracture Therapeutics - Products under Development by Companies
- Fracture Therapeutics - Products under Investigation by Universities/Institutes
- Companies Involved in Fracture Therapeutics Development
- Fracture - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Drug Profiles
- Fracture Therapeutics - Drug Profile Updates
- Fracture Therapeutics - Discontinued Products
- Fracture Therapeutics - Dormant Products
- Fracture - Product Development Milestones
- Featured News & Press Releases
- Appendix
- Methodology
- Coverage
- Secondary Research
- Primary Research
- Expert Panel Validation
- Contact Us
- Disclaimer
Companies Mentioned:
- Amgen Inc.
- Eli Lilly and Company
- Kaken Pharmaceutical Co.,Ltd.
- Radius Health, Inc.
For more information visit http://www.researchandmarkets.com/research/dc444e6b/fracture_pipelin
Source: Global Markets Direct